Haemagglutinin of Influenza A Virus Is a Target for the Antiviral Effect of NorakinR

References

1. Appleyard G. 1977; Amantadine-resistance as a genetic marker for influenza viruses. Journal of General Virology 36:249–255
   [Google Scholar]
2. Daniels R. S., Douglas A. R., Skehel J. J., Wiley D. C. 1983; Analysis of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. Journal of General Virology 64:1657–1662
   [Google Scholar]
3. Ghendon Y., Klimov A., Blagoveshenskaya O., Ghenkina D. 1979; Investigation of recombinants of human influenza and fowl plague viruses. Journal of General Virology 43:183–191
   [Google Scholar]
4. Hay A. J., Bellamy A. R., Abraham G., Skehel J. J., Brand C. M., Webster R. G. 1977a; Procedures for characterization of the genetic material of candidate vaccine strains. Developments in Biological Standardization 39:15–24
   [Google Scholar]
5. Hay A. J., Lomniczi B., Bellamy A. R., Skehel J. J. 1977b; Transcription of the influenza virus genome. Virology 83:337–345
   [Google Scholar]
6. Hosaka Y., Yasuda Y., Fukai K. 1983; Hemolysis by liposomes containing influenza virus haemagglutinins. Journal of Virology 46:1014–1017
   [Google Scholar]
7. Kawasaki K., Sato S. B., Ohnishi S. 1983; Membrane fusion activity of reconstituted vesicles of influenza virus haemagglutinin glycoproteins. Biochimica et biophysica acta 733:286–290
   [Google Scholar]
8. Lenard J., Bailey C. A., Miller D. K. 1982; pH dependence of influenza A virus-induced haemolysis is determined by the haemagglutinin gene. Journal of General Virology 62:353–355
   [Google Scholar]
9. Maeda T., Kawasaki K., Ohnishi S. 1981; Interaction of influenza virus hemagglutinin with target membrane lipids is a key step in virus-induced hemolysis and fusion at pH 5.2. Proceedings of the National Academy of Sciences, U,. S,. A 78:4133–4137
   [Google Scholar]
10. Markushin S. G., Isachenko V. A., Molibog E. V., Zakstelskaya L. Ya., Ghendon Y. Z. 1981; Gene homology and antigenic specificity of envelope proteins of avian influenza virus strains possessing haemagglutinin Havl. Acta virologica 25:65–70
    [Google Scholar]
11. Presber H. W., Schroeder C., Hegenscheid B., Heider H., Reefschlager J., Rosenthal H. A. 1984; Antiviral activity of Norakin^R (triperiden) and related anticholinergic anti-Parkinson drugs. Acta virologica 28:501–507
    [Google Scholar]
12. Sato B. S., Kawasaki K., Ohnishi S. 1983; Hemolytic activity of influenza virus hemagglutinin glycoproteins activated in mildly acidic environments. Proceedings of the National Academy of Sciences, U,. S,. A 80:3153–3157
    [Google Scholar]
13. Skehel J. J., Bayley P. M., Brown E. G., Martin S. R., Waterfield M. D., White J. M., Wilson I. A., Wiley D. C. 1982; Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proceedings of the National Academy of Sciences, U,. S,. A 79:968–972
    [Google Scholar]
14. Vernier V. G. 1981; Antiparkinsonism drugs. Burger’s Medicinal Chemistry II pp 413–430 4th edn Edited by Wolff M. E. New York: John Wiley and Sons;
    [Google Scholar]